Michael Grosso

Global Head of Specialty Medicine Clinical Development at Daiichi Sankyo

Michael A. Grosso MD, FACS currently serves as the Vice President and Global Head of Clinical Development for Specialty Medicine at Daiichi Sankyo, Inc., a position held since December 2010, having previously advanced through roles including Executive Director of Cardiovascular Clinical Development. Additionally, Michael A. Grosso is an Advisory Board Member at Perosphere Technologies. Prior experience includes serving as Director of Medical Advisor for Cardio/Thrombosis at sanofi-aventis and holding academic and clinical roles at the University of Pennsylvania and UMDNJ/Cooper University. Michael A. Grosso earned an MD from the University of Pennsylvania School of Medicine and a BS in Biology from the University of the Sciences in Philadelphia.

Location

Philadelphia, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Daiichi Sankyo

21 followers

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.


Industries

Headquarters

Tokyo, Japan

Employees

1,001-5,000

Links